Notícia

Industry Analysis

Genetically manipulated virus successfully kills tumor cells

Publicado em 03 julho 2019

Por Peter Moon  |  Agência FAPESP

The virus has also made tumor cells more susceptible to chemotherapy drugs, preventing tumor growth, and even eradicating tumors in a few cases.

A team at the São Paulo State Cancer Institute (ICESP), Brazil has successfully used genetically modified virus to destroy tumor cells when injected into mice with prostate cancer. The virus has also made tumor cells more susceptible to chemotherapy drugs, preventing tumor growth, and even eradicating tumors in a few cases. The research team was led by Bryan Eric Strauss, Head, Viral Vector Laboratory at the Center for Translational Research in Oncology (CTO), ICESP. The research has been mentioned in the journal, Gene Therapy. The research was backed by Sanofi, FAPESP, as part of the Thematic Project titled “Cancer gene therapy: strategic positioning for translational studies,” and Brazil’s National Council for Scientific and Technological Development.

Straus explains that they used a combination of gene therapy and chemotherapy to combat prostate cancer in mice. The gene was injected into the genetic code of an adenovirus, in the laboratory, and the altered virus was then injected directly into the tumors in the mice. The team chose the p53 gene, as they thought would be most effective as a tumor suppressant. The p53 gene controls essential aspects of cell death and is found in both humans as well as rodents. Firstly, the team implanted human prostate cancer cells in the mice and waited until the tumors grew. Then the virus was injected straight into the tumors. This process was repeated multiple times, and once, the team also systematically introduced cabazitaxel, a common drug used in chemotherapy, along with the virus.

When the genetically modified virus infected the tumor cells, it was able to infiltrate the cell nucleus and cause the death of the cell. The p53 gene was especially effective at killing the cells in prostate cancer. Strauss explained that individual treatments involving p53 or cabazitaxel alone were not fully effective in inhibiting tumor growth, but the combination was extremely effective in killing the tumors. The team is hoping to refine these methods by conducting various experiments to find out whether they can be administered to human patients.

Essa notícia também repercutiu nos veículos:
Folha.com Estadão.com IstoÉ Dinheiro online BOL UOL Estado de Minas online IstoÉ online UOL Portal R7 Folha de S. Paulo O Estado de S. Paulo Correio Braziliense online Terra Guarulhosweb Tribuna do Agreste Tribuna do Sertão Metro News Jornal do Oeste (Toledo, PR) online Correio Popular online Tribuna do Interior online Portal do Holanda Meon Diário de Notícias online Folha da Região (Araçatuba, SP) online Tarobá News Folha de Londrina online Mix Vale O Diário do Norte do Paraná online A Crítica (MS) online Correio do Papagaio online Diário do Sudoeste (Pato Branco, PR) online Repórter Diário A Tarde (BA) online Tribuna PR Hoje em Dia online Folha Vitória online Diário do Grande ABC online Gazeta online Aqui Notícias online Portal da Enfermagem Esteta Portal N10 HiperNotícias O Liberal (Americana, SP) online Folha de Valinhos online A Semana News Central das Notícias Jornal da Ciência online Jornal da Cidade (Bauru, SP) online IG Sociedade Científica Planeta online LabNetwork 2A+ Farma Plantão News (MT) W Rádio Brasil Planeta online Instituto Oncoguia Giro MT FA Notícias Acesse News O Documento online O Atual Portal MT Portal Lapada Lapada Diário da Saúde RM Consult Gazeta do Povo online Canaltech Finanças Yahoo! Urgente News Algomais online Abradilan - Associação Brasileira dos Distribuidores de Laboratórios Nacionais Gestão Ambiental Amazônia Brasil Rádio Web Antena 1 Alô Tatuapé Jornal Joseense News Perfil News Saúde em ação NewsLab online Luiza Cosméticos Bem Pra Você Oficial Diário Potiguar Diário Nacional O Liberal (PA) Gazeta de S. Paulo online TV Vertentes Dica do tio Blog do Mauro